Galactose ( DrugBank: Galactose )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
222	一次性ネフローゼ症候群	4

222. 一次性ネフローゼ症候群

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01113385 (ClinicalTrials.gov)	October 2009	28/4/2010	Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome	Effect of Oral Galactoseon the Level of Focal Sclerosis Permeability Factor and Proteinuria in Child ...	Focal Segmental Glomerulosclerosis;Steroid Resistant Nephrotic Syndrome	Drug: D-Galactose	Children's Research Institute	National Kidney Foundation	Completed	2 Years	21 Years	All	7	N/A	United States
2	NCT00816504 (ClinicalTrials.gov)	December 2008	31/12/2008	Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5	Effect of Galactoseon Permeability Factor in Patients With Focal Segmental Glomerulosclerosis (FSGS) ...	Focal Segmental Glomerulosclerosis	Drug: Galactose	North Shore Long Island Jewish Health System	Medical College of Wisconsin	Withdrawn	2 Years	60 Years	Both	0	Phase 1	United States
3	NCT00814255 (ClinicalTrials.gov)	December 2008	22/12/2008	Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial	Novel Therapies for Resistant Focal Segmental Glomerulosclerosis	Focal Segmental Glomerulosclerosis	Drug: Adalimumab;Drug: Lisinopril, losartan, and atorvastatin;Drug: galactose	New York University School of Medicine	University of Michigan;The Cleveland Clinic;National Institute of Diabetes and Digestive and Kidney ...	Completed	1 Year	65 Years	All	32	Phase 2	United States;Canada
4	NCT00816478 (ClinicalTrials.gov)	December 2008	31/12/2008	Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor	Effect of Galactoseon Permeability Factor in Patients With Focal Segmental Glomerulosclerosis (FSGS) ...	Focal Segmental Glomerulosclerosis	Drug: Galactose	North Shore Long Island Jewish Health System	NULL	Terminated	2 Years	60 Years	Both	15	Phase 1	United States

First Previous1Next Last